Very low LDL-C Levels
Amgen presents new repatha® (evolocumab) data at aha 2022
Watch Amgen's latest callAmgen (NASDAQ:AMGN) Q2 2026 Earnings Call · Replay · Aug 4Read the transcript of Amgen (NASDAQ:AMGN) Q2 2026 Earnings CallEarlier from Amgen
- Amgen presents new Phase 2 data that show olpasiran delivers significant reduction in lipoprotein(a) levels
- Amgen announces webcast of 2022 credit suisse global healthcare conference
- Amgen reports third quarter 2022 financial results
- Amgen to webcast investor call at AHA 2022
- Amgen announces webcast of 2022 third quarter financial results
Later from Amgen
- Amgen announces webcast of 2022 evercore isi healthcare conference
- Amgen to webcast investor call at wcirdc 2022
- Amgen presents new AMG 133 Phase 1 clinical data at WCIRDC 2022
- Amgen announces 10% increase in 2023 first quarter dividend
- Amgen to host webcast investor call following announced acquisition of horizon therapeutics
Follow Amgen into a list and get an email when it puts out news.
Follow Amgen